Released: Monday 25th February 2019

Some good news on pharmaceutical testing here.

The sectoral annex for pharmaceuticals allows U.S. and UK regulators to rely on each other's GMP inspections of pharmaceutical manufacturing facilities, thereby reducing unnecessary costs and duplicative efforts and allowing the reallocation of regulatory resources to where they are most needed.